Artery Global: Korea Immersion Program – A Multi-Stage, High-Opportunity Medical Market Exploration
VCBeat
Internet Medical Health Media
In 2024, VCBeat will launch the China Medical Global Expansion Practice Camp, offering an immersive overseas study tour and on-the-ground consulting services to medical enterprises with innovative medical products and intentions to expand their markets. The Practice Camp will visit overseas markets such as Indonesia, Russia, Brazil, South Korea, and Japan, helping a wide range of medical enterprises match with corresponding resources. The first stop of the Practice Camp has selected a developed, regulated, high-profit, and undervalued blue ocean in the medical sector—South Korea。VCBeat to Partner with VentureBlick, bridging scarce resources in South Korea’s healthcare industry to facilitate efficient market entry for enterprisesSouth Korean Market。
Clinical medical data and regulatory mechanisms have gained high international recognition, enabling the accumulation of mature market operational experience.
By 2022, Seoul had ranked first among global cities for clinical trials for three consecutive years; South Korea ranked fifth in the industry-led clinical trial market.
The regulatory level for domestically produced and imported drugs and vaccines in South Korea is at2022reached in the yearWHO The Highest Level of Medical Product Regulatory OversightML4(Maturity Level 4)
World-leading medical facilities and services, welcoming innovation, with extensive health insurance coverage and high reimbursement rates
Three hospitals in Seoul, South Korea, ranked among the top 40 of the 2024 World’s Best Hospitals, marking the highest number from any Asian market; they have garnered acclaim for patient satisfaction, facility conditions, and resource allocation.
The South Korean government's health insurance covers almost all residentsAverage reimbursement rate for medical products among the general publicfor80%, with residents' out-of-pocket payment ratio being20%
The two countries will strengthen medical cooperation, driven by strong demand for overseas products and their cultural and geographic proximity.
South Korea’s healthcare expenditure as a percentage of GDP was nearly 1.5 times that of China (2020)
The South Korean medical device market over the past five yearsAverage annual growth rate exceeding8%, Chinese medical devicesMedical devices have generally increased their share of imports.
Pay by August 10 to enjoy the early-bird price, plus receive complimentary exclusive global expansion consulting.
August 10–30: Pay to enjoy early bird pricing
*Includes four nights’ accommodation at a four-star hotel in Seoul’s central business district, daily breakfast, dinner on the day of arrival, lunches and dinners from Day 2 to Day 4, interpretation services for main activities, and all required transportation as outlined in the itinerary. International round-trip airfare is not included. Spaces are limited; registration will close once full.
VCBeat-Kayla
WeChat ID: 18896085363
Scan the QR code to inquire and register for the event.
VCBeatFounded in 2014, VCBeat is a leading media and research institution specializing in the life and health sector. Focusing on this domain, it provides services such as brand communication, research consulting, data monitoring, resource matchmaking, and overseas expansion support to enterprises, government industrial parks, investment institutions, and other stakeholders across the industry chain. Since its establishment, VCBeat has earned the trust of government agencies, innovation centers, investment firms, and startups. It has received investments from several renowned institutions, including Legend Capital, BV Baidu Ventures, Honghui Capital, Changling Capital, Yifang Group, and Weilai Capital.Since 2021, VCBeat has continuously focused on overseas expansion and international cooperation, hosting the China Medical Device Overseas Expansion Conference and overseas matchmaking events for multiple consecutive years. Collaborating with resources from countries including South Korea, the United Kingdom, Belgium, the Philippines, Malaysia, Turkey, Canada, Finland, Singapore, Ireland, Germany, Spain, and Indonesia, VCBeat is committed to becoming a world-class industrial service provider.
Ventureblick (Wanchuang Puli)It is a one-stop platform for the global expansion of medical innovations, facilitating the precise internationalization of local innovations by integrating global resources. Leveraging its online international cooperation platform, Discovery, along with multiple offline solutions, the company connects startups, small and medium-sized enterprises (SMEs), and large medical companies seeking international growth with a global network of multi-disciplinary medical experts, investment institutions, distributors, overseas service providers, and other partners, thereby promoting the internationalization of medical innovations. Headquartered in Singapore, the company has overseas branches and local teams in South Korea, India, Germany, and China. It collaborates with over 3,000 specially appointed experts across more than 60 countries and 30 professional fields, and partners with over 300 local market allies. WanChuang Puli has successfully helped numerous medical innovation enterprises achieve milestone developments, including overseas market validation, technology introduction, production collaboration, overseas market access, product distribution, overseas financing, cooperative negotiations, and international brand enhancement.